Home    Back

 205. Fragile X syndrome related disease
 [ 3 clinical trials,    3 drugs（DrugBank: 2 drugs),    21 target genes / 22 target pathways ] 

Searched query = "Fragile X syndrome related disease", "Fragile X associated tremor/ataxia syndrome", "FXTAS"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement		Last_Refreshed_
on		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02603926October 201516 December 2017Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With AllopregnanoloneTreatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With AllopregnanoloneFragile X-associated Tremor/Ataxia SyndromeDrug: AllopregnanoloneRandi J. Hagerman, MDRecruiting50 Years85 YearsAll15Phase 2United States
2NCT02197104January 201516 December 2017Citocoline for Treatment of FXTASPhase 2 Study of Citocoline for Treatment in Fragile X-associated Tremor/Ataxia SyndromeBalance and Cognitive Deficits in Fragile X-associated Tremor Ataxia SyndromeDrug: citocolineRush University Medical CenterNot recruiting18 Years90 YearsAll10Phase 2United States
3NCT00584948September 200716 December 2017Memantine Treatment in Fragile X-Associated Tremor/Ataxia SyndromeCharacterization and Treatment of CNS Abnormalities in Premutation Carriers: A Double-Blind Placebo-Controlled Trial of MemantineFragile X-Associated Tremor/Ataxia Syndrome;Fragile X Premutation CarriersDrug: Memantine;Drug: PlaceboUniversity of California, DavisNational Institute on Aging (NIA);Forest LaboratoriesNot recruiting30 Years80 YearsAll94N/AUnited States